Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026

Rhea-AI Summary

Pacira BioSciences (Nasdaq: PCRX) announced it will report its second quarter 2026 financial results after U.S. market close on Tuesday, August 4, 2026. A live conference call and webcast will follow at 4:30 p.m. ET, with pre-registration required for telephone Q&A participation and a replay available on the company’s investor website for about two weeks.

News Market Reaction – PCRX

-0.74%

1 alert

-0.74% Session close to close

$1.01B Market Cap

0.0x Rel. Volume

In the Jul 22 session, PCRX declined 0.74%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The two prior earnings-date notices were followed by 1.84% and 1.49% 24-hour reactions, giving this ...

Analysis

The two prior earnings-date notices were followed by 1.84% and 1.49% 24-hour reactions, giving this scheduling event a positive historical reference. Recent insider activity was Net Selling; the announced results remain the next disclosed checkpoint.

Key Figures

Reporting period: Q2 2026 Reporting date: August 4, 2026 Conference call time: 4:30 p.m. ET +1 more

4 metrics

Reporting period Q2 2026 Financial results scheduled for release

Reporting date August 4, 2026 After the close of U.S. markets

Conference call time 4:30 p.m. ET Following the results release

Webcast replay Approximately two weeks Replay availability following the call

Previous Earnings date Reports

2 past events · Latest: Apr 16 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 16	earnings date notice	Neutral	+1.8%	Scheduled first-quarter results after market close with a 4:30 p.m. ET call.
Feb 12	earnings date notice	Neutral	+1.5%	Scheduled fourth-quarter and full-year results after market close with a webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Both prior same-tag earnings-date notices were followed by positive 24-hour reactions of 1.84% and 1.49%, averaging 1.67%.

Key Terms

non-opioid

1 terms

non-opioid medical

"innovative, non-opioid pain therapies"

Non-opioid describes medicines or therapies that relieve pain or treat conditions without using opioid drugs, which act on the brain’s opioid receptors. For investors, non-opioid products matter because they often face fewer addiction and regulatory risks, may win faster approvals or wider adoption, and can open new markets much like a different tool in a toolbox that solves the same problem without the same safety concerns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRISBANE, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its second quarter 2026 financial results after the close of the U.S. markets on Tuesday August 4, 2026. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.

For listeners who wish to participate in the question and answer session via telephone, please pre-register here. All registrants will receive dial-in information and a PIN allowing them to access the live call. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com. For those unable to participate in the live call, a replay of the webcast will be available on the Pacira website for approximately two weeks following the call.

About Pacira

Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera®º, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing a pipeline of clinical-stage assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy, is in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit www.pacira.com.

Investor Contact:

Pacira BioSciences, Inc.
Christian Pedetti, (973) 254-4387
Christian.Pedetti@pacira.com

FAQ

When will Pacira (PCRX) report its Q2 2026 financial results?

Pacira plans to report its Q2 2026 financial results on Tuesday, August 4, 2026, after U.S. markets close. According to Pacira, the release will be followed by a live conference call and webcast that same afternoon.

What time is the Pacira (PCRX) Q2 2026 earnings conference call?

Pacira’s Q2 2026 earnings conference call is scheduled for 4:30 p.m. ET on August 4, 2026. According to Pacira, the live call will follow the financial results release issued after the U.S. market close.

How can investors access the Pacira (PCRX) Q2 2026 earnings webcast?

Investors can access Pacira’s Q2 2026 earnings webcast via the “Events” page at investor.pacira.com. According to Pacira, the live audio webcast will stream the conference call and be archived for replay for about two weeks.

How do I register to join the Pacira (PCRX) Q2 2026 call by phone?

To join by phone, listeners must pre-register using the provided registration link. According to Pacira, all registrants will receive dial-in details and a unique PIN to access the live earnings call and participate in the Q&A session.

Will a replay be available for the Pacira (PCRX) Q2 2026 earnings call?

Yes, a replay of Pacira’s Q2 2026 earnings webcast will be available on its investor website. According to Pacira, the archived webcast can be accessed for approximately two weeks following the live conference call.